Sapacitabine is an orally available nucleoside analog proagent that is structurally related to cytarabine.
| Molecular Weight | 490.64 |
| Formula | C26H42N4O5 |
| CAS Number | 151823-14-2 |
| Form | Solid |
| Solubility (25°C) | DMSO 33.33 mg/mL (ultrasonic) |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog |
| Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
| Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
| Km factor | 3 | 6 | 12 | 8 | 5 | 20 |
| Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
| Animal A Km |
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
[2] James M Cleary, et al. Mol Cell. Biomarker-Guided Development of DNA Repair Inhibitors
[5] Xiaojun Liu, et al. Expert Opin Investig Drugs. Sapacitabine for cancer
| Related Nucleoside Antimetabolite/Analog Products |
|---|
| 8-Chloroguanosine
8-Chloroguanosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. |
| FMAU
FMAU is a thymidine analogue. |
| Xylocytidine
Xylocytidine is a cytidine analog. |
| N3-Allyluridine
N3-Allyluridine is a uridine analog. |
| Homouridine
Homouridine, is an uridine analogue. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
